Symrise stock gains as terpene business sale to Mutares reshapes portfolio

Published on 09/01/2026 at 21:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock is edging higher on September 1, 2026 as the German fragrance and flavors group agrees to sell its US terpene ingredients business to Mutares, while analysts raise their stance and the share trades firmly in the MDAX.

Pop-Art-Comic eines Parfümeurs beim Mischen von Duftölen im Labor, Symrise AG DE000SYM9999 — Symrise AG (DE000SYM9999) Pop-Art-Comic illustriert Parfümeur beim Mischen bunter Duftöle im Labor dynamisch, Illustration mit AI erstellt.

Symrise stock (ISIN DE000SYM9999) is trading firmly on September 1, 2026 as the German fragrance and flavors group signs a definitive agreement to sell its US terpene ingredients business AmeriTerpenes LLC to private equity investor Mutares, a move that will trigger a mid-double-digit million euro non-cash loss in the 2026 annual accounts according to an EQS release and specialist media coverage.

Portfolio reshaped by AmeriTerpenes sale

According to an EQS announcement reported by finanzen.ch, Symrise disclosed in Holzminden on September 1, 2026 that it has signed an agreement to divest AmeriTerpenes LLC, its terpene ingredients unit in the United States, to Munich based investor Mutares SE and Co KGaA, with completion subject to customary closing conditions and regulatory approvals.

The company expects the carve out to result in a mid double digit million euro non cash disposal loss that will be recognized in Symrise's financial statements for fiscal year 2026, a charge that will not affect cash flow but will weigh on reported earnings for that period.

Analyst upgrade supports Symrise stock

Market data compiled by MarketScreener on September 1, 2026 indicate that Symrise stock was recently quoted around 93.04 EUR on the Tradegate venue, up 0.91% on the day, with a year to date performance of 34.81% and a market capitalization of about 14.65 billion EUR, underlining that the shares are trading near the upper end of their recent range.

The same MarketScreener overview shows a last closing price of 92.20 EUR as of August 31, 2026 and an average analyst target price of 96.69 EUR, implying an upside of roughly 4.9% from that close and placing the stock moderately below the consensus fair value level monitored by the portal.

Go deeper

More on Symrise stock and key figures

Read additional headlines and regulatory disclosures on Symrise and follow how the AmeriTerpenes transaction and analyst views feed into the share price and market capitalization.

Symrise stock news and filings Investor Relations

Fragrance and care products at the core

Symrise focuses its business on fragrance, flavor and care solutions for consumer goods and food producers, and in recent quarters has highlighted growth in its Fragrance division including Consumer Fragrance and Fine Fragrance segments, underscoring the strategic rationale of concentrating capital and management attention on higher margin care and wellness activities while ring fencing non core terpene ingredients.

Symrise stock and MDAX positioning

Symrise stock is listed in Germany and trades actively on venues such as Tradegate, with the company positioned in the MDAX index, making it a mid cap benchmark component in the domestic DACH market and a relevant peer for investors following the European fragrance and specialty chemicals space.